Short answer

Implement multi-stage continuous bioreactor systems where host cell physiology can be precisely controlled upstream to maximize downstream product yield and process stability.

Field: Commercial Production
Source: Viruses (2018)
Method: Experimental and Mathematical Modelling
Evidence: Strong effect

Connecting bioreactors in series allows for optimized host bacteria physiology, leading to significantly higher bacteriophage yields. This commercial production research insight is drawn from a 2018 study published in Viruses. Using Experimental and mathematical modelling, researchers explored how this design variable affects real-world outcomes. The key design takeaway: Implement multi-stage continuous bioreactor systems where host cell physiology can be precisely controlled upstream to maximize downstream product yield and process stability.

Study

Commercial ProductionHigh ImpactStrong effect

Continuous Bioreactor Systems Boost Bacteriophage Production by 100-Fold

Connecting bioreactors in series allows for optimized host bacteria physiology, leading to significantly higher bacteriophage yields.

Viruses · 2018

Key Findings

01Continuous production of E. coli T3 phages at titres of 10^11 PFU/mL was achieved.
02Controlling host reactor dilution rates (0.1–0.6 hr⁻¹) significantly influenced intracellular phage production capability.
03Decoupling host bacterial growth from phage production suppressed phage-resistant mutants, enabling stable operation.
04Host bacterium physiology directly impacted phage burst size and overall process productivity.

Application

Design takeaway

Implement multi-stage continuous bioreactor systems where host cell physiology can be precisely controlled upstream to maximize downstream product yield and process stability.

How to apply

For any bioprocess requiring high yields of a specific microbial product, consider a multi-stage continuous fermentation approach to optimize intermediate cell states before product induction.

Project actions

01When designing a bioprocess, consider how to optimize the conditions for the host organism before introducing the production phase.
02Investigate the use of continuous flow systems for improved efficiency and yield in microbial production projects.

Method & Evidence

AimHow can continuous stirred tank bioreactors, connected in series, be utilized to optimize host bacteria physiology for high-throughput bacteriophage production?

MethodExperimental and Mathematical Modelling

ProcedureTwo continuous stirred tank bioreactors were connected in series, with a third acting as a holding tank. The first bioreactor propagated host bacteria in a synthetic medium, controlling dilution rates to influence bacterial physiology. The downstream reactors were used for phage production. Mathematical models were used to analyze process dynamics and sensitivity.

ContextBiopharmaceutical manufacturing, microbial fermentation

Variables

IVDilution rate of the host bacteria bioreactor

DVBacteriophage titre (PFU/mL), phage burst size, lag time, adsorption rate

CVSynthetic medium composition, glucose concentration as limiting substrate, temperature, pH, type of host bacteria and bacteriophage

Strengths & Limitations

Strengths

+Demonstrates a novel, scalable approach for high-yield bacteriophage production.
+Utilizes both experimental and mathematical modelling for robust analysis.

Limitations

The complexity of setting up and maintaining multiple continuous bioreactors can be a significant practical challenge for smaller-scale design projects.

Reliability & validity

The use of mathematical modelling and achieving consistent high titres over several days suggests good reliability. The direct correlation between dilution rate and physiological state, and subsequent impact on phage production, supports validity.

Think critically

To what extent can the principles of decoupling growth and production stages be applied to other biomanufacturing processes beyond bacteriophages?

Design Principles

"Process intensification through controlled, sequential bioreactor stages can optimize biological production by decoupling critical physiological states."

This research demonstrates a scalable method for producing high volumes of bacteriophages, crucial for applications like phage therapy. By decoupling bacterial growth from phage production and controlling bacterial physiology, manufacturers can achieve greater productivity and stability in their processes.

What This Means for Your Design

Imagine growing bacteria in one tank, then moving them to another to make viruses. By carefully controlling the first tank, the bacteria become super-producers, leading to way more viruses in the second tank.

How to use in your project

1.Reference this study when discussing strategies for optimizing microbial fermentation processes for yield and scalability.

Add to My Project

Quick Cite

Paragraph starter

This research highlights the effectiveness of continuous stirred tank bioreactors in series for optimizing host physiology to enhance bacteriophage production. By decoupling bacterial growth from phage production and precisely controlling dilution rates in upstream reactors, significant increases in phage titres (up to 10^11 PFU/mL) were achieved, demonstrating a scalable and stable manufacturing approach.

Source

Viruses

High Throughput Manufacturing of Bacteriophages Using Continuous Stirred Tank Bioreactors Connected in Series to Ensure Optimum Host Bacteria Physiology for Phage Production

journal · 2018

View source

Questions About This Research

What does the research say about continuous bioreactor systems boost bacteriophage production by 100-fold?: Implement multi-stage continuous bioreactor systems where host cell physiology can be precisely controlled upstream to maximize downstream product yield and process stability. Evidence: Viruses (2018).
Why does "Continuous Bioreactor Systems Boost Bacteriophage Production by 100-Fold" matter for design?: This research demonstrates a scalable method for producing high volumes of bacteriophages, crucial for applications like phage therapy. By decoupling bacterial growth from phage production and controlling bacterial physiology, manufacturers can achieve greater productivity and stability in their processes.
How can designers apply this research?: Implement multi-stage continuous bioreactor systems where host cell physiology can be precisely controlled upstream to maximize downstream product yield and process stability.
What were the main findings?: Continuous production of E. coli T3 phages at titres of 10^11 PFU/mL was achieved.. Controlling host reactor dilution rates (0.1–0.6 hr⁻¹) significantly influenced intracellular phage production capability.. Decoupling host bacterial growth from phage production suppressed phage-resistant mutants, enabling stable operation.. Host bacterium physiology directly impacted phage burst size and overall process productivity.
What research method was used?: Experimental and Mathematical Modelling.
How strong is the evidence?: Evidence strength is rated Strong effect, based on a 2018 journal from Viruses.
What should I do differently in my next project?: For any bioprocess requiring high yields of a specific microbial product, consider a multi-stage continuous fermentation approach to optimize intermediate cell states before product induction.
What are the limitations?: The study focused on a specific host-bacterium and phage system; results may vary for other microbial systems. Long-term stability beyond several days was not extensively explored.